Boston Sci introduces Charger catheter

Boston Scientific ($BSX) has launched its Charger PTA balloon catheter for a range of peripheral angioplasty procedures. Charger is the company's third new peripheral balloon catheter introduced in this year. "The Charger PTA Balloon Catheter is designed to deliver results in both routine and challenging cases," said Jeff Mirviss, president of the company's peripheral interventions division. "With a low profile and tapered tip, it is engineered to provide excellent push without sacrificing track. The Charger PTA Balloon Catheter complements our growing portfolio of interventional devices for peripheral vasculature procedures." Boston Scientific release 

Suggested Articles

AI-based drug molecule designer XtalPi has secured a mammoth funding round totaling $318.8 million, from global banking and tech investors.

LabCorp has licensed a blood test from Genfit designed to identify patients with risky cases of the liver disease NASH.

Philips has launched a compact, single-use device for physically clearing potentially dangerous blood clots lodged in the arms and legs.